Skip to Content

Carbetapentane / diphenhydramine Side Effects

Applies to carbetapentane/diphenhydramine: oral suspension extended release

Cardiovascular

Cardiovascular side effects have included hypotension, headache, palpitations, tachycardia, and extrasystoles.[Ref]

Hematologic

Hematologic side effects have included hemolytic anemia, thrombocytopenia, and agranulocytosis.[Ref]

Nervous system

Nervous system side effects have included sedation, sleepiness, dizziness, disturbed coordination, fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesia, vertigo, acute labyrinthitis, tinnitus, and convulsions.[Ref]

Ocular

Ocular side effects have included blurred vision and diplopia.[Ref]

Gastrointestinal

Gastrointestinal side effects have included epigastric distress, anorexia, nausea, vomiting, diarrhea, and constipation.[Ref]

Genitourinary

Genitourinary side effects have included urinary frequency, difficult urination, urinary retention, and early menses.[Ref]

Respiratory

Respiratory side effects have included thickening of bronchial secretions, tightness of chest or throat, wheezing, and nasal stuffiness.[Ref]

Hypersensitivity

Hypersensitivity side effects have included urticaria, drug rash, anaphylactic shock, and photosensitivity.[Ref]

General

General side effects have included excessive perspiration, chills, and dryness of mouth, nose and throat.[Ref]

References

1. "Product Information. Dytan-AT (carbetapentane-diphenhydrAMINE)." Hawthorn Pharmaceuticals, Madison, MS.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide